FREE Daily Stock Alerts From Stock-PR.com
Proper Power & Energy, Inc. (OTC:PPWE) a Tampa-based independent oil and gas exploration and production company, has announced the next stage of its Western U.S. operations. The Company met with the executives of Thrust Resources Inc. and EQ Resources Inc. in Dallas, Texas on January 20, 2011. The meeting focused on a joint venture for the Central Utah Prospect between the Companies. This was the initial meeting between Clint Brower, CEO and Chairman of EQ Resources, and Andrew Kacic, the newly named President of Proper Power & Energy Inc.
The next steps will be circulating a memorandum of understanding followed upon definitive agreements. “We look forward to expedite future discussions of both Companies working together to mutually reach our Utah objectives,” stated Andrew Kacic.
About Proper Power & Energy:
Proper Power & Energy was formed in 2006 as an exploration and production company for oil and gas. The organization is committed to utilizing a very dynamic system of research and testing, and as a result of this extensive research and testing, have selected several sites with very good to excellent potential for productivity.
Heartland Financial USA Inc. (Nasdaq:HTLF) reported net income of $6.5 million for the quarter ended December 31, 2010, compared to a net loss of $7.9 million for the fourth quarter of 2009. Net income available to common stockholders was $5.2 million, or $0.31 per diluted common share, for the quarter ended December 31, 2010, compared to a net loss of $9.2 million, or $0.56 per diluted common share, for the fourth quarter of 2009. Return on average common equity was 8.06 percent and return on average assets was 0.50 percent for the fourth quarter of 2010, compared to negative 14.76 percent and negative 0.92 percent, respectively, for the same quarter in 2009.
Heartland Financial USA, Inc., through its bank subsidiaries, provides commercial and retail banking services to businesses and individuals. Its deposit products include checking and other demand deposit, negotiable order of withdrawal, savings, money market, individual retirement, as well as certificates of deposits and other time deposits.
Cisco Systems, Inc. (Nasdaq:CSCO) announced that Blair Christie has been appointed Chief Marketing Officer, Worldwide Government Affairs, effective immediately. Ms. Christie, previously Senior Vice President of Global Corporate Communications, succeeds Susan Bostrom, who has decided to leave the company to pursue new professional opportunities after serving in an advisory role throughout the transition. Ms. Christie will continue to report to Cisco Chairman and CEO John Chambers. "As an integral part of the Cisco leadership team, Blair is the natural choice to continue to lead our efforts to strengthen and broaden the Cisco brand," said John Chambers, chairman and CEO, Cisco. "Blair's most recent experience leading Cisco's global corporate communications organization has given her a unique understanding of how external audiences view and engage with Cisco.
Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (NYSE:IP)-based networking and other products related to the communications and information technology industry worldwide.
Myriad Genetics Inc. (Nasdaq:MYGN) announced that it will release its financial results for its second fiscal quarter ended December 31, 2010, at the close of market on Thursday, January 27, 2011. The Company will host a conference call on Thursday, January 27, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; and Mark C. Capone, President of Myriad Genetic Laboratories, Inc. To participate on the call, callers may dial (800) 954-1053 or (212) 231-2915 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21507216.
Myriad Genetics, Inc., a healthcare company, focuses on the development and marketing of novel molecular diagnostic products. It commercializes predictive medicine, personalized medicine, and prognostic medicine products. Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.
“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Alzheimer’s illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer’s type (PDDAT), or Alzheimer’s-is the most common sort of dementia. This unique incurable, degenerative, and deadly disorder was first explained German born professional as well as neuropathologist Alois Alzheimer in 1906 and was called after him. Most often, it really is determined in individuals over 65 years of age, although the less-prevalent early-onset Alzheimer’s can take place much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer’s is predicted to threaten 1 in 85 people today worldwide by the year 2050.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates receiving 1,000,000 shares of free trading shares from a third party (Mohamad Nehmeh) for two (2) weeks of advertisment services for Proper Power & Energy, Inc. (OTC:PPWE).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.